angiotensinconvert
enzym
share
homolog
angiotensinconvert
enzym
ace
inhibit
ace
inhibitor
main
role
degrad
ang
ii
result
format
angiotensin
ang
oppos
action
ang
ii
increas
ang
ii
level
thought
upregul
activ
defici
mice
ang
ii
level
approxim
doubl
wildtyp
mice
whilst
ang
level
almost
undetect
thu
play
crucial
role
ra
oppos
action
ang
ii
consequ
benefici
role
mani
diseas
hypertens
diabet
cardiovascular
diseas
express
decreas
surprisingli
current
therapeut
strategi
involv
augment
express
use
adenovirus
recombin
compound
diseas
therebi
afford
organ
protect
type
integr
membran
glycoprotein
express
activ
tissu
highest
express
observ
kidney
endothelium
lung
heart
extracellular
domain
enzym
contain
singl
catalyt
metallopeptidas
unit
share
sequenc
ident
sequenc
similar
catalyt
domain
ace
howev
reninangiotensin
system
ra
signal
pathway
act
homeostat
regul
vascular
function
system
action
includ
regul
blood
pressur
natriuresi
blood
volum
control
howev
ra
also
play
import
local
role
regul
region
blood
flow
control
trophic
respons
rang
stimuli
ra
compos
number
differ
regulatori
compon
effector
peptid
facilit
dynam
control
vascular
function
health
diseas
figur
mani
compon
oppos
function
accommod
rapid
coordin
respons
specif
trigger
exampl
angiotensin
ang
metabolis
dipeptid
carboxypeptidas
angiotensinconvert
enzym
ace
form
angiotensin
ii
ang
ii
ang
ii
metabolis
carboxypeptidas
produc
vasodil
angiotensin
ang
histor
ace
ang
ii
key
focu
clinic
intervent
target
ra
pathogen
action
howev
recent
studi
also
demonstr
import
maintain
balanc
ra
inde
set
cardiovascular
system
particular
may
import
ace
regul
local
level
ang
ii
ang
therein
balanc
ra
activ
exampl
shown
acquir
genet
defici
result
increas
tissu
circul
level
ang
ii
reduc
level
ang
contrast
ace
ko
mice
modestli
reduc
circul
ang
ii
tissu
level
significantli
modifi
possibl
substanti
amount
ang
ii
gener
nonac
pathway
degrad
pathway
ang
ii
limit
paper
specif
examin
action
bodi
discuss
potenti
role
health
variou
diseas
state
unlik
ace
function
carboxypeptidas
rather
dipeptidas
activ
antagon
convent
ace
inhibitor
major
substrat
appear
ang
ii
although
peptid
may
also
degrad
albeit
lower
affin
exampl
abl
cleav
ctermin
amino
acid
angiotensin
vasoact
bradykinin
desargkallidin
also
known
desarg
lysbradykinin
well
possibl
target
noncatalyt
ctermin
domain
show
sequenc
ident
collectrin
protein
recent
shown
import
role
neutral
amino
acid
reabsorpt
intestin
kidney
highli
consist
action
carboxypeptidas
remov
amino
acid
becom
avail
reabsorpt
cytoplasm
tail
also
contain
calmodulinbind
site
may
influenc
shed
catalyt
ectodomain
addit
also
associ
integrin
function
independ
angiotensinas
activ
abnorm
activ
ra
contribut
develop
progress
atherosclerot
vascular
diseas
independ
addit
induct
system
hypertens
vasoconstrict
ang
ii
number
direct
proatherosclerot
effect
vascular
wall
includ
promot
inflamm
endotheli
dysfunct
oxid
stress
endotheli
cell
vascular
smooth
muscl
cell
migrat
growth
prolifer
thrombosi
contrast
major
product
ang
rang
antiinflammatori
antioxid
effect
oppos
ang
ii
vasculatur
inde
infus
ang
abl
attenu
vascular
dysfunct
atherosclerosi
genet
suscept
apolipoprotein
e
knockout
apo
ko
mice
possibl
increas
activ
ma
receptor
type
angiotensin
receptor
thought
balanc
ang
ii
ang
repres
import
drive
factor
vascular
diseas
progress
consequ
also
like
play
import
role
atherosclerot
plaqu
develop
certainli
express
reduc
establish
atherosclerot
plaqu
proatherosclerot
state
diabet
howev
direct
evid
develop
progress
atherosclerot
plaqu
recent
becom
avail
shown
apo
ko
mice
defici
associ
increas
plaqu
accumul
figur
compar
observ
follow
angiotensin
ii
infus
possibl
relat
increas
proinflammatori
respons
leukocyt
recruit
adhes
nascent
atherosclerot
lesion
gener
regard
one
first
step
toward
plaqu
format
healthi
endothelium
gener
support
bind
white
blood
cell
show
aortic
endothelium
doubl
ko
mice
show
increas
adhes
label
leukocyt
addit
genet
defici
associ
upregul
put
mediat
atherogenesi
cytokin
adhes
molecul
role
ra
action
emphas
find
ra
blockad
abl
prevent
atherogenesi
doubl
ko
mice
data
emphas
potenti
util
replet
strategi
reduc
atherosclerosi
particularli
combin
ace
inhibit
intervent
reduc
activ
ra
see
activ
ra
known
key
mediat
hypertens
intervent
block
ra
activ
wide
use
blood
pressur
lower
agent
antihypertens
efficaci
agent
partli
mediat
abil
reduc
ang
ii
signal
howev
antihypertens
effect
convent
ra
blockad
also
partli
determin
abil
ace
inhibitor
angiotensin
receptor
blocker
arb
intern
journal
peptid
increas
circul
level
ang
moreov
inhibit
vascular
action
ang
spontan
hypertens
rat
shr
receiv
ra
blockad
attenu
antihypertens
respons
agent
given
major
sourc
ang
data
suggest
consequ
influenc
develop
hypertens
also
potenti
respons
treatment
certainli
express
abnorm
shr
one
genet
compon
phenotyp
track
locu
addit
defici
associ
modest
systol
hypertens
although
mous
genet
background
significantli
alter
cardiovascular
phenotyp
ko
mice
also
heighten
hypertens
respons
ang
ii
infus
associ
exagger
accumul
ang
ii
kidney
ra
also
implic
pathogenesi
central
hypertens
particular
rostral
ventrolater
medulla
rvlm
relay
point
provid
supraspin
excitatori
input
sympathet
preganglion
neuron
regul
blood
pressur
shr
express
reduc
rvlm
persist
overexpress
rvlm
result
signific
attenu
high
blood
pressur
model
addit
inject
inhibitor
nucleu
tractu
solitarii
reduc
reflex
bradycardia
respons
baroreceptor
stimul
rat
suggest
addit
role
central
control
baroreceptor
respons
addit
effect
blood
pressur
natriuresi
atherogenesi
ra
play
critic
pathophysiolog
role
maintain
subsequ
subvert
cardiac
function
set
progress
heart
failur
cardiac
ra
upregul
almost
model
cardiac
injuri
includ
volum
overload
myocardi
infarct
heart
failur
kidney
ra
upregul
appear
homeostat
respons
restor
cardiac
function
exampl
ang
ii
inotrop
growth
factor
cardiac
myocyt
stimul
compensatori
hypertrophi
ang
ii
also
import
left
ventricular
remodel
follow
myocardi
infarct
afterloadinduc
cardiac
hypertrophi
howev
long
term
action
lead
progress
function
loss
cardiac
fibrosi
synthesi
extracellular
matrix
increas
ang
ii
key
role
ra
activ
develop
progress
cardiac
failur
support
find
number
differ
model
blockad
ra
abl
attenu
prevent
cardiac
damag
independ
blood
pressur
lower
heart
repres
primari
pathway
metabol
ang
ii
defici
mice
result
earli
cardiac
hypertrophi
figur
acceler
advers
postmyocardi
infarct
ventricular
remodel
furthermor
appear
activ
napdh
oxidas
system
ko
figur
increas
lv
mass
ko
mice
versu
mice
unpublish
data
vs
control
mice
p
phox
subunit
play
critic
role
model
defici
also
result
progress
cardiac
fibrosi
age
andor
cardiac
pressur
overload
chang
revers
follow
treatment
ace
inhibitor
receptor
blocker
suggest
balanc
ace
heart
import
drive
factor
progress
cardiac
diseas
ra
also
play
import
role
renal
physiolog
pathophysiolog
adult
kidney
predominantli
express
proxim
tubul
lumin
brush
border
despit
presenc
unoppos
ace
activ
elev
ang
ii
level
kidney
function
renal
develop
normal
knockout
mous
comparison
ace
angiotensinogen
receptor
defici
result
number
alter
kidney
morpholog
suggest
least
healthi
state
may
limit
role
regul
renal
develop
howev
action
appear
come
state
ra
activ
much
like
ang
major
product
show
limit
renal
effect
healthi
state
profound
benefit
diabet
kidney
state
associ
renal
damag
activ
exampl
defici
mice
report
show
increas
agerel
glomerulosclerosi
suscept
mous
model
enhanc
renal
ang
iiinduc
renal
oxid
stress
result
greater
renal
injuri
similarli
diabet
kidney
downregul
tubular
figur
associ
albuminuria
tubular
injuri
inhibit
result
augment
renal
damag
inde
form
ckd
includ
diabet
express
report
reduc
tubul
howev
studi
report
glomerular
express
may
increas
human
kidney
diseas
possibl
differenti
express
pattern
glomerular
ra
activ
intrins
high
lung
major
sourc
ace
therefor
major
site
system
ang
ii
synthesi
also
highli
express
lung
pulmonari
appear
role
regul
balanc
circul
ang
iiang
level
ang
ii
induc
pulmonari
vasoconstrict
respons
hypoxia
import
prevent
shunt
patient
pneumonia
lung
injuri
local
increas
ang
ii
product
also
trigger
increas
vascular
permeabl
facilit
pulmonari
edema
acut
respiratori
distress
syndrom
ard
ra
appear
crucial
maintain
oxygen
possibl
widespread
lung
injuri
would
otherwis
result
complet
pulmonari
shutdown
certainli
ard
model
knockout
mice
display
sever
symptom
diseas
compar
wildtyp
mice
overexpress
appear
protect
see
interestingli
protein
also
appear
entrypoint
receptor
sever
acut
respiratori
syndrom
sar
coronaviru
given
key
role
degrad
ang
ii
gener
ang
number
studi
explor
potenti
treatment
strategi
use
human
recombin
adenovir
ad
anim
diseas
model
exampl
overexpress
human
endotheli
cell
attenu
ang
iiinduc
oxid
stress
subsequ
increas
monocyt
adhes
similarli
rabbit
recombin
express
vector
stabil
atherosclerot
plaqu
induc
balloon
injuri
abdomin
aorta
treatment
lentivir
vector
contain
result
lower
blood
pressur
hypertens
mice
follow
ang
ii
infus
strategi
upregul
replenish
thought
benefici
diabet
nephropathi
exampl
diabet
replenish
mous
model
type
diabet
attenu
diabet
kidney
injuri
well
reduc
blood
pressur
use
ad
similar
benefici
effect
streptozotocininduc
diabet
shown
attenu
glomerular
mesangi
cell
prolifer
blood
pressur
oxid
stress
fibrosi
contrast
studi
potenti
util
supplement
cardiac
diseas
remain
controversi
express
fail
human
heart
gener
increas
consist
find
elev
level
ang
set
importantli
overexpress
cardiac
myocyt
result
conduct
disturb
week
age
ultim
lead
lethal
ventricular
arrhythmia
sever
fibrosi
may
normal
express
high
level
myocyt
although
present
endocardium
cardiac
cell
howev
studi
use
transgen
overexpress
cardiac
demonstr
partial
protect
heart
ischemiainduc
heart
failur
inde
recent
studi
use
shown
benefici
cardiac
effect
howev
indic
appear
like
first
test
clinic
treatment
ard
murin
model
treatment
catalyt
activ
recombin
protein
improv
symptom
acut
lung
injuri
wildtyp
mice
well
knockout
mice
clinic
trial
often
fatal
condit
underway
perhap
clinic
interest
howev
potenti
augment
vasculoprotect
effect
ace
inhibit
arb
million
patient
take
agent
worldwid
theori
would
achiev
prevent
feedback
escap
ra
blockad
enhanc
gener
ang
subsequ
intern
journal
peptid
signal
ma
receptor
receptor
certainli
inhibit
attenu
effect
ra
blockad
vitro
vivo
could
make
respons
convent
ra
blockad
effect
durabl
problem
convent
ra
blockad
highli
effect
anim
model
vascular
renal
diseas
mean
difficult
explor
potenti
improv
howev
chronic
intraven
infus
ang
nonpeptid
ma
receptor
agonist
abl
improv
saltinduc
suppress
endotheliumdepend
vasodilat
mesenter
arteri
male
spraguedawley
rat
action
modifi
angiotensin
receptor
blocker
losartan
suggest
effect
enhanc
ang
ma
axi
may
benefici
even
set
convent
ra
blockad
although
enhanc
gener
ang
whether
also
provid
synergist
benefit
remain
establish
rather
provid
exogen
altern
approach
augment
increas
endogen
express
exampl
hypertens
shr
alltran
retino
acid
increas
express
lower
blood
pressur
level
prevent
vascular
damag
unfortun
retino
acid
broader
action
make
potenti
util
therapeut
limit
howev
compound
increas
activ
could
also
benefici
treatment
condit
activ
decreas
one
exemplar
xanthenon
xnt
molecul
select
follow
structurebas
screen
compound
would
stabil
activ
form
therebi
enhanc
catalyt
efficaci
experiment
studi
compound
shown
enhanc
activ
dosedepend
manner
significantli
decreas
blood
pressur
shr
rat
wildtyp
wki
rat
furthermor
improv
cardiac
function
revers
myocardi
perivascular
renal
fibrosi
shr
also
observ
xnt
also
shown
promis
treat
pulmonari
hypertens
ph
exampl
rat
model
ph
treatment
xnt
shown
reduc
elev
right
ventricular
systol
pressur
right
ventricular
hypertrophi
increas
pulmonari
vessel
wall
thick
interstiti
fibrosi
model
thrombu
format
use
shr
wki
rat
xnt
also
shown
antithrombot
action
reduc
platelet
attach
reduc
thrombu
format
compound
come
clinic
trial
issu
solubl
restrict
formul
howev
drug
class
may
prove
suitabl
integr
compon
ra
highli
express
vasculatur
kidney
lung
heart
action
peptid
signal
balanc
offset
ace
action
appear
critic
varieti
diseas
state
includ
hypertens
diabet
age
renal
impair
cardiovascular
diseas
defici
lead
modest
physiolog
chang
howev
state
ra
activ
loss
appear
far
import
develop
progress
diseas
contrast
augment
express
either
directli
recombin
indirectli
via
agonist
like
xnt
may
import
benefit
relev
treatment
rang
condit
